| Ytd | -0.29% | |
| 1y | -46.19% |
| Open | Prev Close | 1.70 | Low | High | Mkt Cap | 10.11M | |||
| Vol | 0.00 | Avg Vol | 742.52K | EPS | -235.75 | P/E | -0.01 | Forward P/E | N/A |
| Beta | 0.57 | Short Ratio | 0.09 | Inst. Own | 0.36% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 01-30 | 50-d Avg | 2.24 | 200-d Avg | 55.79 | 1yr Est | 0.00 |
OST News
20% of OST-HER2 treated dogs survived 2-year vs. 1% in control group (p = 0.00995) Over 15,000 dogs
75% 2.5-year overall survival for OST-HER2 vs. 47% pooled historical control (p = 0.003), with no ne
The Company confirms that it will release 2.5 year overall survival data from Phase 2b clinical tria
$5.5 million financing that closed on April 2, 2026 together with $5.7 million in capital raised in
Appointment strengthens medical, regulatory, and commercial leadership as Company prepares to comple
30/04/2026 Not for distribution, directly or indirectly, in or into the United States or any jurisdi
30/04/2026 Not for distribution, directly or indirectly, in or into the United States or any jurisdi
Conference call scheduled for Thursday, April 30, 2026, at 8:30 am ET to review new OST-HER2 immune
Regulatory feedback recent from April 2026 EU EMA and Australian TGA meetings Remaining Q2-2026 regu
New York, New York--(Newsfile Corp. - April 17, 2026) - Bronstein, Gewirtz and Grossman, LLC, a nati
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered L
NEW YORK, April 17, 2026 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to share
New York, New York--(Newsfile Corp. - April 16, 2026) - Bronstein, Gewirtz and Grossman, LLC, a nati
NEW YORK, April 16, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has bee
Key Dates and Disclosure Events Shareholders Need to Know April 14, 2025: OST closes at $0.78. April
New patent application covers treatment-emergent immune signature related to 'turning cold tumors ho
New York, New York--(Newsfile Corp. - April 15, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nation
Promise vs. Reality: The Ostin Technology Performance Gap That Cost Investors $950 Million NEW YORK,
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered L
NEW YORK, April 14, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has
On Friday morning, 446 companies hit new 52-week lows.
On Tuesday, 838 companies hit new 52-week lows.
On Thursday, 1076 companies hit new 52-week lows.
On Wednesday, 340 stocks hit new 52-week lows.
During Monday's trading, 1214 companies set new 52-week lows.
On Wednesday, 807 companies reached new 52-week lows.